Dr. Jonathan Davis is Vice-Chair of Pediatrics and the Associate Director of the Tufts Clinical and Translational Science Institute at Tufts Medical Center, an Attending Neonatologist at Boston Children’s Hospital, and Professor of Pediatrics at Tufts University School of Medicine. His research has focused on neonatal drug and device development for the prevention and treatment of a variety of neonatal conditions. He has authored approximately 300 manuscripts and book chapters and received numerous grant awards from the NIH, the FDA, the March of Dimes, and many others. He is currently funded by NIH and FDA to develop better diagnostics and outcome measures for clinical trials and novel drugs and devices to improve outcomes in children.

Dr. Davis is Chair of the Neonatal Advisory Committee and an ad hoc member of the Pediatric Review Committee in the Office of Pediatric Therapeutics at FDA as well as a Senior Global Policy Advisor in Pediatrics for the Critical Path Institute. These positions permit him to work closely with governments, regulators, academic leaders, industry, and advocacy groups worldwide to help pass important legislation to promote the development of crucial therapeutics for infants and children.